Literature DB >> 2170534

Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.

L Polonelli1, F Fanti, S Conti, L Campani, M Gerloni, M Castagnola, G Morace, C Chezzi.   

Abstract

Yeast killer toxin cell wall receptors of Candida albicans were observed by indirect immunofluorescence using an affinity purified rabbit anti-idiotypic antiserum. The antiserum had been raised against a monoclonal antibody neutralizing the in vitro activity of a killer toxin produced by a selected strain of Hansenula anomala UCSC 25F. This simple procedure permitted the location of killer toxin cell wall receptors in various morphological phases of the yeast cells. The use of the indirect immunofluorescence technique with anti-idiotypic antibodies may have potential value in determining the occurrence of killer toxin receptors in other microbial systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170534     DOI: 10.1016/0022-1759(90)90031-p

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.

Authors:  Marcello Donini; Chiara Lico; Selene Baschieri; Stefania Conti; Walter Magliani; Luciano Polonelli; Eugenio Benvenuto
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

4.  Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.

Authors:  N Séguy; J C Cailliez; P Delcourt; S Conti; D Camus; E Dei-Cas; L Polonelli
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

5.  Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.

Authors:  L Polonelli; N Séguy; S Conti; M Gerloni; D Bertolotti; C Cantelli; W Magliani; J C Cailliez
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 6.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

Authors:  María D Moragues; Miren J Omaetxebarria; Natalia Elguezabal; María J Sevilla; Stefania Conti; Luciano Polonelli; José Pontón
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Authors:  Luciano Polonelli; Walter Magliani; Stefania Conti; Luisa Bracci; Luisa Lozzi; Paolo Neri; Daniela Adriani; Flavia De Bernardis; Antonio Cassone
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Antibody Peptide based antifungal immunotherapy.

Authors:  Walter Magliani; Stefania Conti; Laura Giovati; Pier Paolo Zanello; Martina Sperindè; Tecla Ciociola; Luciano Polonelli
Journal:  Front Microbiol       Date:  2012-06-01       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.